Richard Blackley, the Chief Financial Officer of Oscar Health Inc (OSCR, Financial), executed a sale of 24,642 shares of the company on June 4, 2024. The transaction was filed on the same day as per the SEC Filing. Following this transaction, the insider now owns 642,920 shares of Oscar Health Inc.
Oscar Health Inc operates as a health insurance company, primarily engaging in the provision of health insurance products and services. The company's platform integrates technology and personalized service to offer health insurance coverage through direct-to-consumer, broker channels, and strategic partnerships.
Over the past year, Richard Blackley has sold a total of 179,190 shares and has not made any purchases of the company's stock. This recent transaction is part of a broader trend observed within the company, where there have been 26 insider sells and no insider buys over the last year.
On the day of the sale, shares of Oscar Health Inc were priced at $19.45, valuing the company with a market cap of approximately $4.495 billion. According to the GF Value, the intrinsic value of the stock is estimated at $11.61, indicating that the stock is significantly overvalued with a price-to-GF-Value ratio of 1.68.
The valuation metrics such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow are used in determining the GF Value, along with adjustments based on the company's past performance and expected future business outcomes.
Investors and stakeholders may consider these insider trading trends and valuation metrics when assessing their investment decisions in Oscar Health Inc.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
